ArticleJournal of clinical hypertension (Greenwich, Conn.)2020
Patterns of hypertension management in France in 2015: The ESTEBAN survey.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed.
- Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort.Journal of the National Cancer Institute · 2023Trial
- Global trends in hypertension prevalence, awareness, treatment, and control.Current opinion in nephrology and hypertension · 2026Review
- A retrospective analysis of influence of the establishment of intelligent hypertension diagnosis and treatment center on blood pressure data management and treatment compliance of patients with hypertension in Sichuan, China, and its clinical value in accurate diagnosis and treatment.BMC cardiovascular disorders · 2025Article
- Echocardiography assessment of aortic elasticity as a vascular marker in hypertensive vs. healthy individuals.Scientific reports · 2025Article
- Article
- Vascular ageing manifestations and hypertension in the community.American journal of preventive cardiology · 2025Article
- Targeting senescence and GATA4 in age-related cardiovascular disease: a comprehensive approach.Biogerontology · 2025Review
- Signaling Pathways (TNF-α-NF-κB, TLR2-TLR4 as well as ROS-MDA) and Cardiac Damages during Cardiac Surgeries (Coronary Stenting, Permanent Pacemaker Implantations, Radiofrequency Ablations).Current topics in medicinal chemistry · 2025Article
- The impact of diagnosis-related group payment on the hospitalization expenditure and medical quality of public hospitals in China.PloS one · 2025Article
- The Relationship Between Cardiometabolic Index and New-Onset Diabetes in Adults Aged Over 45: A Longitudinal Analysis Based on CHARLS.International journal of endocrinology · 2025Article
- Article
- Impact of Smoking Reduction Scenarios on the Burden of Myocardial Infarction in the French Population Until 2035.Clinical epidemiology · 2024Article
- Article
- Hypertension prevalence in Iran's elderly according to new criteria: the Tehran Geriatric Eye Study.Journal of diabetes and metabolic disorders · 2023Article
- Article
- No association between genetic markers and hypertension control in multiple cross-sectional studies.Scientific reports · 2023Article
- Article
- Association between cannabis use and blood pressure levels according to comorbidities and socioeconomic status.Scientific reports · 2023Article
- Epidemiology of heart failure in young adults: a French nationwide cohort study.European heart journal · 2023Article
- Cardiovascular Risk Assessment among Farmers in French Guiana in 2018-A Screening Program.International journal of environmental research and public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purposes of this study were to describe the hypertensive population and therapeutic management of hypertension in adults between 18 and 74 years of age in France in 2015. Esteban survey is a cross-sectional survey with a clinical examination conducted in a representative sample of French adults aged 18-74 years between 2014 and 2016. Esteban was entirely public-funded. Blood pressure (BP) was measured during clinical examination with a standardized protocol, and pharmacological treatment was collected through the exhaustive Système National des Données de Santé (SNDS) database. Hypertension was defined by systolic BP (SBP)> 140 mm Hg, diastolic BP (DBP)> 90 mm Hg or treatment with BP-lowering drugs. The therapeutic control of treated hypertensive patients was defined by SBP < 140 mm Hg and DBP < 90 mm Hg. Adherence to drug treatment was defined as more than 80% of days covered by BP-lowering drug per year. The prevalence of hypertension was 31.3%. 74.7% of aware hypertensive participants taking an antihypertensive drug, and 57.7% of them were treated with a single antihypertensive pharmacological class. Overall, among hypertensives, 24.3% had a satisfactory BP control. Only 49.7% of treated hypertensives participants were controlled, and 33.6% of them were adherent to their drug treatment. The prevalence of hypertension in France remains high, with only 74.7% of the aware hypertensive participants receiving pharmacological therapy and only 48.9% of aware hypertensives with a BP at goal. More effective measures are needed to improve clinical management of hypertension in France.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.